Nanodisc - Page 7 of 36 - DIMA Biotechnology

Select Expression Host

E.coli
(0)
E.coli expression system
(0)
HEK293
(716)

Select Conjugate

PE Conjugate
(0)
Unconjugated
(1)
Biotinylated
(0)
PE-conjugated
(0)

Full Length Transmembrane Proteins

Human SCN4A full length protein-synthetic nanodisc

SKU: FLP100725 Target: SCN4A

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human SCN3A full length protein-synthetic nanodisc

SKU: FLP100724 Target: SCN3A

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human SCN2A full length protein-synthetic nanodisc

SKU: FLP100723 Target: SCN2A

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human NMDE1 full length protein-synthetic nanodisc

SKU: FLP100722 Target: NMDE1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human ZACN full length protein-synthetic nanodisc

SKU: FLP100721 Target: ZACN

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human KCTD1 full length protein-synthetic nanodisc

SKU: FLP100720 Target: KCTD1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human BEST4 full length protein-synthetic nanodisc

SKU: FLP100719 Target: BEST4

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human BACD1 full length protein-synthetic nanodisc

SKU: FLP100718 Target: BACD1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human KCD20 full length protein-synthetic nanodisc

SKU: FLP100717 Target: KCD20

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human KCTD6 full length protein-synthetic nanodisc

SKU: FLP100716 Target: KCTD6

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human KCNG3 full length protein-synthetic nanodisc

SKU: FLP100715 Target: KCNG3

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human KCTD7 full length protein-synthetic nanodisc

SKU: FLP100714 Target: KCTD7

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human KCD11 full length protein-synthetic nanodisc

SKU: FLP100713 Target: KCD11

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human BEST3 full length protein-synthetic nanodisc

SKU: FLP100712 Target: BEST3

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human KCD18 full length protein-synthetic nanodisc

SKU: FLP100711 Target: KCD18

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human CXB4 full length protein-synthetic nanodisc

SKU: FLP100710 Target: CXB4

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human KCD12 full length protein-synthetic nanodisc

SKU: FLP100709 Target: KCD12

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human CA2D4 full length protein-synthetic nanodisc

SKU: FLP100708 Target: CA2D4

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human SHKB1 full length protein-synthetic nanodisc

SKU: FLP100707 Target: SHKB1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Full Length Transmembrane Proteins

Human KCNH7 full length protein-synthetic nanodisc

SKU: FLP100706 Target: KCNH7

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Posts found

The structure of MSP-Nanodisc (left) and Synthetic Nanodisc (right)

Synthetic Nanodisc, A Promising Solution for “Undruggable” Membrane Proteins

[...]

26
Jul

The glucagon receptor (GCGR)：A Key Target in Glucose Metabolism

On June 25, 2024, at the 2024 American Diabetes Association (ADA) Scientific Sessions, Suzhou Innovent Biologics [...]

29
Aug

GLP1R Target: Not Just for Blood Sugar Control and Weight Loss, but a Potential Breakthrough for Anti-Nausea in Weight Loss Medications

Currently, the most popular GLP1-based monotherapy, Semaglutide, controls blood sugar by promoting insulin secretion and [...]

19
Aug

GIP Receptor (GIPR): A Novel Target for Glycemic Control and Weight Loss

On February 27, 2024, Viking Therapeutics announced the results of their Phase IIa clinical study [...]

08
Aug

Discover DIMA at Membrane Protein Paris 2024

2024-07-26

Membrane proteins are essential for cell functions such as maintaining cellular physiological processes, playing crucial [...]

STEAP1 – A Therapeutic Target for Prostate Cancer

At the 2024 ASCO Annual Meeting, HANGZHOU DAC BIOTECHNOLOGY (abbreviated as DAC Biotech) presented preclinical [...]

03
Jul

The structure of Claudin proteins enables the Claudins tight protein family to effectively maintain the polarity of epithelial and endothelial cells.

Tumor Immune Target – Claudin18.2

Since Ganymed unveiled the efficacy data of Zolbetuximab (IMAB362), the anti-Claudin18.2 monoclonal antibody, for the [...]

18
Apr

ActRII – A Novel Drug Target that Preserves Skeletal Muscle Mass and Enhances Fat Loss

In the previous article, we focused on the popular drug target for weight loss, G [...]

10
Apr

20-HETE Receptor (GPR75) Signaling in Endothelial Cells

GPR75 – An Emerging Target for Weight Loss Drugs

When it comes to weight loss medications, one cannot overlook the remarkable success of Semaglutide [...]

01
Apr

Proposed role of HSD17B13 in modulating disease progression in NAFLD

HSD17B13-NASH Therapeutic Emerging Target

On November 30, 2023, Inipharm, a pharmaceutical company focused on severe liver diseases, announced the [...]

19
Feb

Pages found

Mammalian Cell Protein Production Platform

revolutionizing-drug-development-synthetic-nanodiscs

Synthetic Nanodisc

Case Study on Membrane Protein

Product case studies

DiMPro^TM Full Length Transmembrane Proteins

FAQ

Company Introduction

Company News

Posts found

Synthetic Nanodisc, A Promising Solution for “Undruggable” Membrane Proteins

The glucagon receptor (GCGR)：A Key Target in Glucose Metabolism

GLP1R Target: Not Just for Blood Sugar Control and Weight Loss, but a Potential Breakthrough for Anti-Nausea in Weight Loss Medications

GIP Receptor (GIPR): A Novel Target for Glycemic Control and Weight Loss

Discover DIMA at Membrane Protein Paris 2024

STEAP1 – A Therapeutic Target for Prostate Cancer

Tumor Immune Target – Claudin18.2

ActRII – A Novel Drug Target that Preserves Skeletal Muscle Mass and Enhances Fat Loss

GPR75 – An Emerging Target for Weight Loss Drugs

HSD17B13-NASH Therapeutic Emerging Target

Pages found

Login